Erlotinib HCl Powder CAS 183319-69-9 Anticancer Erlotinib HCl Pharmaceutical Erlotinib Hydrochloride

• Customization: Available
• Powder: Yes
• Customized: Customized
• Certification: GMP, ISO 9001, USP, BP
• Suitable for: Adult
• State: Powder
• Purity: >98%
• Sample: Available
• OEM: Available
• MOQ: 1kg
• Keyword 1: Erlotinib Hydrochloride
• Keyword 2: Erlotinib Hydrochloride Powder
• Storage: Dry and Cool Place
• Transport Package: Foil Bag/25kg Drum
• Specification: 98%
• Trademark: /
• Origin: China
• Production Capacity: 10000

Product Description

Description
Erlotinib hydrochloride is a drug used to treat non-small cell lung cancer.
Erlotinib hydrochloride should be stored in a well-closed container at low temperature, keep away from moisture, heat and light.
Uses Selective epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor. Antineoplastic
Erlotinib hydrochloride (trade name Tarceva) is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer. It is a receptor tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR)

Name	Erlotinib Hydrochloride
Grade	Pharmaceutical Grade
Appearance	White powder
Specification	98%

Function and Application
Erlotinib hydrochloride is a small molecule epidermal growth factor receptor tyrosine kinase reversible inhibitor, mainly used for second-line or third-line treatment of locally advanced or metastatic non-small cell lung cancer and the treatment of pancreatic cancer